
The Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to bring <b>antimicrobials</b> under the central regulatory framework. This step aims to strengthen oversight of their quality, safety, and efficacy to effectively address antimicrobial resistance. According to officials, the move comes amid concerns regarding manufacturing licences granted without adequate regulatory scrutiny, including vital studies like bioavailability and stability. The matter is under review as <b>antimicrobial resistance</b> remains a major global public health concern requiring coordinated action.
This page is a shareable card. Download our app to get the full swipe experience!